Physician profile
William Harris
NPI 1548440050
$121,972.13
in general payments reported to CMS, 2019-2025
29 companies · $38K in 2025
The $38K reported for 2025 was more than what 97% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $448 · 2021: $2,268 · 2022: $16K · 2023: $20K · 2024: $45K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $84K · Education: $7,000 · Food and Beverage: $4,732 · Travel and Lodging: $4,660 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $83,840.88 |
| Education | $7,000.00 |
| Food and Beverage | $4,731.61 |
| Travel and Lodging | $4,659.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,880.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $46,318.34 | 2019-2025 | (9520) Igt Devices Undivided, Igt Devices Undivided, Peripheral Vascular Undivided |
| Bard Peripheral Vascular, INC. | $37,351.59 | 2022-2025 | Venovo, Rotarexs 6 F X 135 Cm, Fluency Endovascular Stent Graft |
| Terumo Medical Corporation | $22,874.42 | 2020-2025 | Glidesheath Slender, Azur Cx Detachable, Navicross |
| Cardiovascular Systems INC. | $5,177.25 | 2020-2022 | |
| Abbott Laboratories | $2,970.68 | 2022-2025 | Diamondback Peripheral, Esprit |
| Penumbra, INC. | $1,819.90 | 2023 | Indigo System |
| Medtronic, INC. | $1,466.65 | 2021-2023 | Endurant Iis |
| Nuvasive, INC. | $1,204.97 | 2021 | |
| Cordis US Corp. | $849.55 | 2021-2025 | Precise Pro Rx, Palmaz Blue, Outback |
| Boston Scientific Corporation | $358.50 | 2020-2025 | Varithena Administration Pack |
| Becton, Dickinson and Company | $269.53 | 2025 | Venclose Maven Catheter |
| Inari Medical, INC. | $238.72 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biotronik INC. | $180.03 | 2022 | |
| Bolton Medical INC | $132.94 | 2021 | |
| Janssen Pharmaceuticals, INC | $114.61 | 2022-2023 | Xarelto |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $114.36 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic Vascular, INC. | $101.61 | 2020 | |
| Teleflex LLC | $64.00 | 2022 | |
| Angiodynamics, INC. | $56.96 | 2024 | Alphavac |
| Stryker Corporation | $49.01 | 2025 | Artix Mt, Limflow System |
| Cook Medical LLC | $48.15 | 2021 | |
| Veryan Medical Incorporated | $39.59 | 2025 | Biomimics 3d Vascular Stent System |
| Reflow Medical INC | $35.49 | 2025 | |
| Asahi Intecc USA, INC. | $26.24 | 2021 | |
| Ethicon US, LLC | $26.24 | 2025 | Surgicel Nu-Knit, Prolene, Vistaseal |
| Cardiva Medical, INC. | $25.27 | 2024 | Cardiva Vascade 5f Vcs |
| Cvrx, INC. | $24.03 | 2025 | Barostim Neo System |
| Shockwave Medical, INC | $20.34 | 2025 | |
| Biom'Up Sa | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.